Pharma & Biotech

In a significant consolidation within the biotechnology sector, Swiss pharmaceutical giant Roche has finalized its acquisition of Poseida Therapeutics, effectively...

A landmark court decision has removed the most significant legal threat facing the rapidly expanding market for affordable weight-loss medications....

The story of Absci Corporation presents investors with a puzzling dichotomy. On one hand, the biotechnology firm faces stark financial...

Shares of Aclaris Therapeutics experienced a notable advance today, climbing more than 3.5 percent. This upward movement comes directly on...

Biotechnology firm Ocugen approaches a pivotal moment that could define its trajectory for the coming year. The company's presentation at...

Shares of Voyager Therapeutics have registered notable gains after a series of presentations at investor conferences. The biotechnology company's stock...

Shares of Monopar Therapeutics experienced a significant rally, propelled by encouraging clinical trial developments and a wave of positive analyst...

The biotechnology firm G1 Therapeutics has ceased to be a publicly traded entity following its successful acquisition by the Danish...

Vanda Pharmaceuticals Inc. (Vanda) provided a comprehensive update on its strategic direction and drug development pipeline during the Cantor Global...

Keros Therapeutics Inc (NASDAQ: KROS) is drawing significant market attention as CEO Jasbir Seehra prepares to present at the Wells...